Rona, Gergely http://orcid.org/0000-0003-3222-7261
Zeke, Andras
Miwatani-Minter, Bearach http://orcid.org/0000-0003-1725-2020
de Vries, Maren http://orcid.org/0000-0003-1059-8344
Kaur, Ramanjit
Schinlever, Austin http://orcid.org/0000-0003-3401-0904
Garcia, Sheena Faye http://orcid.org/0000-0002-2716-2638
Goldberg, Hailey V.
Wang, Hui
Hinds, Thomas R.
Bailly, Fabrice
Zheng, Ning
Cotelle, Philippe
Desmaële, Didier
Landau, Nathaniel R.
Dittmann, Meike http://orcid.org/0000-0002-1741-7916
Pagano, Michele http://orcid.org/0000-0003-3210-2442
Funding for this research was provided by:
Foundation for the National Institutes of Health (DA046100, AI122390, AI120898, R01AI143639, R21AI139374, R01CA76584, R35GM136250)
G. Harold and Leila Y. Mathers Foundation
Howard Hughes Medical Institute
Article History
Received: 27 August 2021
Revised: 8 November 2021
Accepted: 10 November 2021
First Online: 3 December 2021
Competing interests
: MP is a cofounder of Coho Therapeutics and is on the SAB of, is a consultant for, and has financial interests in Coho Therapeutics, CullGen, Kymera Therapeutics, Santi Therapeutics, and SEED Therapeutics. NZ is a cofounder and SAB member of Coho Therapeutics Inc. and SEED Therapeutics Inc. NZ also serves as a Consultant and SAB member of Kymera Therapeutics. The other authors declare no competing interests. The NYU Grossman School of Medicine has filed an U.S. patent application on work described here and may seek to license the technology.
: Our study did not include human participants or the use of animals, therefore ethical approval was not required.